Hong Kong-listed innovative drug ETF turnover exceeds 4.5 billion yuan, current increase is 3.33%

Hong Kong's innovative pharmaceutical ETF has a trading volume exceeding 4.5 billion yuan, with a current increase of 3.33%, a premium rate of -0.69%, and a trading volume of 45.35 billion yuan. Compared to the same time yesterday, the trading volume has increased by 45.37%. In the past month, the fund's assets have increased by 29.88%, adding 2.766 billion shares. This fund supports T+0 trading.